We Just Had An Epiphany

Tag: FUNstock Index

Oracle AI data-center illustration showing surging cloud demand, a $664 billion backlog, heavy capital spending and negative free cash flow.

Oracle Stock (ORCL): Can a $664 Billion Backlog Outrun the AI Capex Bill?

Oracle’s cloud-infrastructure revenue surged 121% as remaining performance obligations reached $664 billion. With Larry Ellison still owning roughly 40%, institutions controlling most of the float and valuation sharply compressed, ORCL looks compelling—but heavy debt, negative free cash flow and an enormous AI buildout make execution everything.

Read entire article

Tags: AI chips, Artificial Intelligence, buy or sell ORCL, capital expenditures, cloud computing, Cloud Infrastructure, cloud stocks, data centers, Earnings Summary, featured-epiphany, founder-led companies, free cash flow, FUNstock Index, FunStock Method, GARP investing, growth at a reasonable price, growth stocks, hub-epiphany, hub-insiders, hyperscalers, insider ownership, institutional ownership, Larry Ellison, OCI, OpenAI, Oracle, Oracle Cloud Infrastructure, Oracle earnings, Oracle RPO, Oracle stock, ORCL, ORCL stock, Project Jupiter, remaining performance obligations, risks buying ORCL, Stargate, stock analysis, Tech Stocks, technology stocks, Tencent, Valuation, value investing, why buy ORCL
Graph depicting Shiller P/E ratio (see above) and showing the S&P 500 trades at twice its mean/median or close.

S&P 500 PE Ratio Hits 30: Is a 2026 Bear Market Black Swan Immersion Imminent?

With the S&P 500 trading at nearly twice its historical P/E average, valuations are stretched. Even a 20% drop wouldn’t make stocks cheap. Is 2026 the year gravity reasserts itself?

Read entire article

Tags: Bear Market 2026, BearMarket2026, Black Swan Events Finance, Black Swan Risk, BlackSwan, Capital Preservation, featured-epiphany, Financial Risk, FinancialLiteracy, FUNanc1al, FUNanc1al Edge, FUNanc1al Investing, FunStock Index, How to Invest During a Recession, hub-epiphany, hub-special-files, Investing, Long-Term Investing, Macro Investing, Market Bubble, Market Crash Triggers 2026, Market Cycles, MarketAnalysis, PersonalFinance, Portfolio Diversification Strategies 2026, Robert Shiller, S&P 500, S&P 500 Bear Market 2026, S&P500, Shiller P/E, Shiller PE Ratio Analysis, Stock Market Bubble Signs, Stock Market Valuation, StockMarketCrash, Uncorrelated assets, Wealth
Illustration of a DNA helix transforming into a declining stock chart, representing the financial struggles of a synthetic biology company.

No Bullish Trigger: Ginkgo Bioworks Should Read “Ginkgo Bio… Doesn’t Work”

Ginkgo Bioworks (DNA) has ambitious science and flashy AI rhetoric — but declining revenues, deep losses, and no insider conviction make this a tough stock to love. 🧬📉

Read entire article

Tags: AI in Biotech, Bearish Stocks, Biotech Stocks, buy or sell DNA stock, DNA Stock, featured-epiphany, FUnanc1al Edge, funanc1al humor, Funanc1al Investing, FUNstock Index, Ginkgo Bioworks, hub-epiphany, Jason Kelly, Loss-Making Companies, risks investing in DNA stock, Short Interest, Synthetic Biology, why buy DNA stock